Loading organizations...
Shengshi Yangzi Fund Investment Management, also known as YanFu Investments, specializes in technology-driven quantitative investment strategies. The firm employs scientific quantitative methods, leveraging rigorous research, high-performance computing clusters, and high-throughput big data platforms. Operating as a quantitative hedge fund, its approach focuses on systematic strategies designed to generate sustainable and stable returns for its investors.
The company was established in July 2019 by Gao Kang, a former analyst from Two Sigma Investments. Kang founded the firm with the insight of bringing a robust engineering culture and advanced quantitative methodologies to the Chinese investment landscape, aiming to build a competitive brand in the global financial market. This vision underscores an emphasis on academic rigor and innovative technological application.
YanFu Investments primarily serves a sophisticated base of institutional and high-net-worth investors seeking alpha through systematic quantitative approaches. The firm's long-term vision is to attract and cultivate exceptional talent within an open environment, continually developing state-of-the-art quantitative investment skills. This dedication aims to solidify its position as a leading Chinese quantitative investment manager globally.
Shengshi Investment Management has 1 tracked investment across 1 company. The latest tracked deal is $27.8M Series A in AccuPulse in February 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 7, 2024 | AccuPulse | $27.8M Series A | Shanghai Biopharmaceutical Fund, Shengshi Investment Management | — |